Therapeutics Stocks Q4: AI, Orphan Drugs Drive Growth episode artwork

EPISODE · Apr 23, 2026 · 2 MIN

Therapeutics Stocks Q4: AI, Orphan Drugs Drive Growth

from The Daily News Now! Business

Therapeutics stocks wrapped up Q4 strong, beating revenue estimates by 7.1%. AbbVie led with a 10% Y/Y revenue increase, but stocks dipped due to lost exclusivity. Novavax saw a 66.6% revenue jump, yet shares fell. United Therapeutics stock surged 23% despite a revenue miss. Vertex Pharmaceuticals missed earnings per share, causing shares to fall. Halozyme Therapeutics revenue soared, but other misses tanked stocks. The sector holds firm amid earnings noise, setting up for a pivotal 2026 with AI innovations and regulatory hurdles. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/e6461af7574174ce

NOW PLAYING

Therapeutics Stocks Q4: AI, Orphan Drugs Drive Growth

0:00 2:01

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Daily News Now! Business?

This episode is 2 minutes long.

When was this The Daily News Now! Business episode published?

This episode was published on April 23, 2026.

What is this episode about?

Therapeutics stocks wrapped up Q4 strong, beating revenue estimates by 7.1%. AbbVie led with a 10% Y/Y revenue increase, but stocks dipped due to lost exclusivity. Novavax saw a 66.6% revenue jump, yet shares fell. United Therapeutics stock...

Can I download this The Daily News Now! Business episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!